The AML Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy
Steering Committee About Us Newsletter Contact
Visit:
GVhD Hub Lymphoma Hub MPN Hub Multiple Myeloma
Steering Committee About Us Newsletter Contact
Types Therapeutics Congresses Trials Expert Opinions
ASH 2020

What are the highlights of SOHO 2020?

Claire Baker
Natasha Fort
Selina Luger
Sep 25, 2020
Share:

During the 2020 Annual Meeting of the Society of Hematologic Oncology (SOHO), the AML Hub was pleased to speak to Selina M. Luger, University of Pennsylvania, Philadelphia, US. We asked: What are the highlights of SOHO 2020 for AML?

What are the highlights of SOHO 2020?

Selina M. Luger discusses the following topics:

  1. The VIALE-A trial
  2. Targeted agents for AML, i.e. IDH inhibitors and FLT3 inhibitors
  3. The recent approval of an oral hypomethylating agent for maintenance in AML
  4. Immunomodulation in AML
Share:
More about...
Claire Baker FLT3 inhibitors Hypomethylating agents IDH1 inhibitors IDH2 inhibitors Immune modulators Natasha Fort Selina Luger SOHO 2020 VIALE-A

Related articles

Newsletter

Subscribe to get the best content related to AML delivered to your inbox every month